UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
| | | |
| Date of Report (Date of earliest event reported): | | January 17, 2008 |
| | | |
BEIJING MED-PHARM CORPORATION
(Exact name of registrant specified in its charter)
| | | | | |
| Delaware | | 000-51409 | | 20-0434726 |
| |
(State or other jurisdiction of
incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification
No.) |
| | | |
600 W. Germantown Pike, Suite 400,
Plymouth Meeting, Pennsylvania | |
19462 |
| |
| (Address of principal executive offices) | | (Zip Code) |
| | | |
| Registrant’s telephone, including area code: | | (610) 940-1675 |
| | | |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (seeGeneral Instruction A.2. below):
| | |
| o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On January 17, 2008, Beijing Med-Pharm Corporation (the “Company”) issued a press release regarding the 8-K/A filed on January 16, 2008 that included certain financial information regarding the acquisition of Hong Kong Fly International Health Care Limited by the Company. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
| | |
| Item 9.01 | | Financial Statements and Exhibits. |
(c) Exhibits.
| | | | | |
| Exhibit Number | | Description of Exhibit |
| | | | | |
| | 99.1 | | | Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | BEIJING MED-PHARM CORPORATION
| |
| Date: January 17, 2008 | By: | /s/ Fred M. Powell | |
| | | Name: | Fred M. Powell | |
| | | Title: | Chief Financial Officer | |
| | | | | |
| Exhibit Number | | Description of Exhibit |
| | | | | |
| | 99.1 | | | Press Release |
